qXR-PTX-PE

qXR-PTX-PE is an artificial intelligence-driven software that analyzes adult chest X-rays to detect suspected pleural effusion and pneumothorax, providing passive notifications for worklist prioritization within the standard radiology workflow. The device's AI algorithm, trained on globally sourced data and validated on independent US datasets, demonstrated high diagnostic accuracy (AUC >0.98 for both conditions) and rapid processing, supporting its utility in assisting clinicians to identify potentially critical findings.

The qXR-PTX-PE is a radiological computer-assisted triage and notification software designed to analyze adult frontal chest X-ray images (AP or PA views) for the presence of suspected critical findings, specifically pleural effusion and/or pneumothorax. It utilizes an artificial intelligence algorithm to identify features suggestive of these conditions and provides a case-level output integrated into the PACS/workstation. This output is intended for worklist prioritization or triage, assisting appropriately trained medical specialists by grouping suspicious exams. Importantly, qXR-PTX-PE functions as a passive notification tool within the standard of care workflow, does not send proactive alerts, and its results are not intended for standalone clinical decision-making or to direct attention to specific image portions beyond the target conditions. The AI algorithm was trained on a diverse dataset sourced globally (74% India, 20.04% EU, 3.9% US, etc.) and its performance was validated using retrospectively collected chest X-rays from various US patient populations, ensuring independence between training and testing data. Ground truth for validation was established by three experienced ABR thoracic radiologists. Clinical testing demonstrated high accuracy, with an Area Under the Curve (AUC) of 0.9894 (Sensitivity 94.53%, Specificity 96.36%) for pneumothorax detection from 613 scans, and an AUC of 0.9890 (Sensitivity 96.22%, Specificity 94.90%) for pleural effusion detection from 1070 scans. The device demonstrated consistent performance across various subgroups, including different genders and age ranges, and achieved an average notification processing time of approximately 10 seconds.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the geographical diversity of the training data (e.g., 74% from India) potentially impact the algorithm's performance nuances and generalizability on patient populations with different demographic or etiological profiles for pneumothorax and pleural effusion, despite testing on US datasets?; What specific visual features or patterns has the AI algorithm learned to identify for pleural effusion and pneumothorax, and how robust is its detection capability against subtle or atypical presentations of these conditions?; Beyond the reported AUC, sensitivity, and specificity, what is the anticipated real-world impact of this passive notification system on radiologist reading times, workflow efficiency, and ultimately, time-to-intervention for critical cases?; How does the qXR-PTX-PE software handle chest X-ray images of suboptimal quality or those containing significant artifacts, and what is its reported failure rate or rate of images it cannot process effectively?; What were the detailed inclusion/exclusion criteria for patient data in the clinical studies, particularly concerning the minimum detectable size/severity of pneumothorax/pleural effusion and the handling of concurrent lung pathologies that might confound AI interpretation?